$76.81
4.696.50%
al cierre: -
$76.29
-0.52-0.67%
After hour: 5:24 PM EDT
Comments
Loading...
Estimaciones de beneficios, BPA e ingresos
Corcept Therapeutics informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Fecha de beneficios
oct 29
Estimación de BPA
$0.150
Estimación de ingresos trimestrales
$218.79M
Ingresos anuales
(a partir de jun 30)
(a partir de jun 30)
$716.08M
Analice el historial de beneficios de Corcept Therapeutics utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
CORT | Corcept Therapeutics | $0.41 | $0.15 | — | — | $182.55M | $218.79M | — | — | 10/29/2025 | |
CORT | Corcept Therapeutics | $0.32 | $0.20 | $0.29 | 45.00% | $163.77M | $201.27M | $194.43M | -3.40% | 07/31/2025 | |
CORT | Corcept Therapeutics | $0.25 | $0.14 | $0.17 | 21.43% | $146.81M | $177.93M | $157.21M | -11.64% | 05/05/2025 | |
CORT | Corcept Therapeutics | $0.28 | $0.37 | $0.26 | -29.73% | $135.41M | $195.74M | $181.89M | -7.08% | 02/26/2025 | |
CORT | Corcept Therapeutics | $0.28 | $0.28 | $0.41 | 46.43% | $123.60M | $171.97M | $182.55M | 6.15% | 10/30/2024 | |
CORT | Corcept Therapeutics | $0.25 | $0.23 | $0.32 | 39.13% | $117.72M | $155.23M | $163.77M | 5.50% | 07/29/2024 | |
CORT | Corcept Therapeutics | $0.14 | $0.22 | $0.25 | 13.64% | $105.65M | $140.80M | $146.81M | 4.27% | 05/01/2024 | |
CORT | Corcept Therapeutics | $0.14 | $0.26 | $0.28 | 7.69% | $103.06M | $129.30M | $135.41M | 4.72% | 02/15/2024 | |
CORT | Corcept Therapeutics | $0.30 | $0.21 | $0.28 | 33.33% | $101.73M | $119.34M | $123.60M | 3.57% | 11/01/2023 | |
CORT | Corcept Therapeutics | $0.24 | $0.15 | $0.25 | 66.67% | $103.39M | $109.71M | $117.72M | 7.30% | 08/02/2023 | |
CORT | Corcept Therapeutics | $0.20 | $0.19 | $0.14 | -26.32% | $93.70M | $104.87M | $105.65M | 0.75% | 05/03/2023 | |
CORT | Corcept Therapeutics | $0.35 | $0.22 | $0.14 | -36.36% | $98.82M | $105.08M | $103.06M | -1.93% | 02/28/2023 | |
CORT | Corcept Therapeutics | $0.30 | $0.22 | $0.30 | 36.36% | $96.13M | $107.59M | $101.73M | -5.45% | 11/03/2022 | |
CORT | Corcept Therapeutics | $0.30 | $0.21 | $0.24 | 14.29% | $91.59M | $101.00M | $103.39M | 2.36% | 08/03/2022 | |
CORT | Corcept Therapeutics | $0.20 | $0.24 | $0.20 | -16.67% | $79.44M | $98.88M | $93.70M | -5.24% | 05/05/2022 | |
CORT | Corcept Therapeutics | $0.27 | $0.21 | $0.35 | 66.67% | $85.73M | $100.57M | $98.82M | -1.74% | 02/15/2022 | |
CORT | Corcept Therapeutics | $0.24 | $0.20 | $0.30 | 50.00% | $86.33M | $97.19M | $96.13M | -1.09% | 11/03/2021 | |
CORT | Corcept Therapeutics | $0.32 | $0.16 | $0.30 | 87.50% | $88.56M | $86.84M | $91.59M | 5.47% | 07/29/2021 | |
CORT | Corcept Therapeutics | $0.34 | $0.21 | $0.20 | -4.76% | $93.25M | $91.81M | $79.44M | -13.48% | 05/06/2021 | |
CORT | Corcept Therapeutics | $0.33 | $0.19 | $0.27 | 42.11% | $87.89M | $87.77M | $85.73M | -2.32% | 02/23/2021 | |
CORT | Corcept Therapeutics | $0.31 | $0.20 | $0.24 | 20.00% | $81.50M | $90.87M | $86.33M | -5.00% | 11/03/2020 |
Corcept Therapeutics (CORT) Ganancias por acción
Monto sorpresa de ganancias trimestrales
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-07-31 | $0.29 | $0.20 | 45.0 % |
| Q1 | 2025-05-05 | $0.17 | $0.14 | 21.4 % |
| Q4 | 2025-02-26 | $0.26 | $0.37 | -29.7 % |
| Q3 | 2024-10-30 | $0.41 | $0.28 | 46.4 % |
Corcept Therapeutics (CORT) Ingresos
Monto sorpresa de ingresos trimestrales
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-07-31 | $194.43M | $201.27M | -3.40 % |
| Q1 | 2025-05-05 | $157.21M | $177.93M | -11.6 % |
| Q4 | 2025-02-26 | $181.89M | $195.74M | -7.08 % |
| Q3 | 2024-10-30 | $182.55M | $171.97M | 6.15 % |
PREGUNTAS FRECUENTES
¿Cuándo Corcept Therapeutics (NASDAQ:CORT) publicará los resultados?
Está previsto que Corcept Therapeutics (CORT) presente resultados el octubre 29, 2025. Los últimos resultados se publicaron el julio 31, 2025 para el Q2.
¿Cuáles han sido los últimos beneficios por acción (BPA) de Corcept Therapeutics (NASDAQ:CORT)?
El BPA real fue de $0.29, que superó la estimación de $0.20.
¿Cuáles fueron los ingresos de Corcept Therapeutics (NASDAQ:CORT)?
Los ingresos reales fueron $194.4M, que no alcanzó la estimación de $201.3M.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.